Drug Interaction Report

Gabapentin and Nalbuphine Injection: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Gabapentin

Gabarone Gralise Horizant Neurontin Relgaabi
+

Nalbuphine Injection

Nubain®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 27 documented Gabapentin interactions, 25 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
unspecified
Evidence
probable
Severity
Major

What happens

An increased risk of serious and/or fatal respiratory depression and sedation

Interaction Deep Dive

Concomitant use of gabapentin and other CNS depressants, such as opioids has resulted in serious, life-threatening, or fatal respiratory depression when coadministered with CNS depressants, including opioids, or in the setting of underlying respiratory impairment. When the decision is made to coadminister gabapentin with another CNS depressant, particularly an opioid, or to prescribe gabapentin to patients with underlying respiratory impairment, monitor patients for symptoms of respiratory depression and sedation, and consider initiating gabapentin at a low dose. The management of respiratory depression may include close observation, supportive measures, and reduction or withdrawal of CNS depressants (including gabapentin)5.

Why it happens (mechanism)

Additive CNS depression

Literature reports

3 reports — tap to read

a) According to the FDA Adverse Event Reporting System (FAERS) database, between January 1, 2012 and October 26, 2017, 49 cases of respiratory depression occurred with gabapentinoids (gabapentin n=15; pregabalin n=34). A respiratory risk factor, including age-related loss of lung function or the use of a CNS depressant, was reported in 92% of cases. Twelve deaths occurred (24%) and all deaths reported at least 1 respiratory risk factor. Small, randomized trials of healthy volunteers have demonstrated that gabapentinoids alone and in combination with opioids depress respiratory function. End-tidal CO(2) increased with additive effect with exposure to pregabalin plus remifentanil, and hourly apneic episodes were more frequent during gabapentin exposure than placebo exposure. Observational studies suggest an increased risk of postoperative respiratory depression with the use of preoperative gabapentinoids compared with no preoperative gabapentinoid exposure 1.

b) Increased somnolence or sedation, dizziness, and nausea occurred per visual analog scale measurement when a single gabapentin enacarbil (CNS depressant) 600 mg dose was given 2 hours after a single 60 mg dose of morphine sulfate extended-release was administered to 18 subjects compared to the agents alone. No changes in Cmax or AUC of gabapentin, morphine, or morphine's active metabolite occurred 2.

c) In a study of 12 volunteers, a single oral dose of 60 mg controlled-release morphine (CNS depressant) was administered 2 hours prior to a single oral dose of 600 mg immediate-release gabapentin. The mean gabapentin AUC value in these patients was 44% greater compared with administration of gabapentin alone. The pharmacokinetics of morphine were not altered 345.

Common questions

Can I take Gabapentin and Nalbuphine Injection together?

An increased risk of serious and/or fatal respiratory depression and sedation Always confirm with your pharmacist or prescriber before making any change.

How serious is the Gabapentin and Nalbuphine Injection interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

From our Q&A

Real reader questions about these medications, each personally answered by our pharmacist:

Questions for your pharmacist

  • Does my dose of Gabapentin or Nalbuphine Injection need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (5)

  1. US Food and Drug Administration (FDA): Drug Safety Communications: FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) when used with CNS depressants or in patients with lung problems. US Food and Drug Administration (FDA). Silver Spring, MD. 2019.
  2. Product Information: HORIZANT(R) oral extended-release tablets, gabapentin enacarbil oral extended-release tablets. GlaxoSmithKline (per FDA), Research Triangle Park, NC, 2013. DailyMed
  3. Product Information: Neurontin(R) oral capsules, tablets, solution, gabapentin oral capsules, tablets, solution. Parke-Davis, New York, NY, 2010. DailyMed
  4. Product Information: GRALISE(R) oral tablets, gabapentin oral tablets. Abbott Laboratories, North Chicago, IL, 2011. DailyMed
  5. Product Information: GABAPENTIN oral caspules, gabapentin oral capsules. Amneal Pharmaceuticals LLC (per Dailymed), Bridgewater, NJ, 2024. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.